Guatemala - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Guatemala Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases rose 10.7% year on year. With 103 Cases in 2019, the country was number 134 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India lead the ranking with 66,255 Cases in 2019, that is an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 103.00 |
| 2018 | 57.00 |
| 2017 | 75.00 |
| 2016 | 75.00 |
| 2015 | 27.00 |
Download all data from 2005 to 2019
How does Guatemala rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 134 |
#134
Armenia
|
103 | 2019 | -1.9 % | -1.5 % | View data | |
| 134 |
#134
Guatemala
|
103 | 2019 | +80.7 % | +10.7 % | View data | |
| 136 |
#136
Rwanda
|
101 | 2019 | +4.1 % | +4.3 % | View data | |